Literature DB >> 1735733

Local hyperthermia enhances cyclophosphamide, ifosfamide and cis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice.

G Wiedemann1, S Roszinski, A Biersack, C Weiss, T Wagner.   

Abstract

Antitumour response and toxicity of locally applied hyperthermia with or without cyclophosphamide, ifosfamide, and cis-diamminedichloroplatinum (cisplatin) have been compared. The model systems were human breast carcinoma (MX1/3) and human sarcoma (S117) grown in nude mice. In order to detect changes of tumour oxygenation intratumoral PO2 and pH were measured before, during and following hyperthermia. In both human tumour lines a monotherapy with one of the cytotoxic drugs or with hyperthermia caused a transient growth delay, while the combination of the same dose of the drugs with hyperthermia (at 43 degrees C for 1 h) resulted in complete tumour remissions. During hyperthermia, in both tumour types oxygenation was improved. Intratumoral pH remained practically unchanged.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735733     DOI: 10.1007/bf01187501

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Influence of extracellular pH on the viability and morphology of tumor cells exposed to hyperthermia.

Authors:  J Overgaard
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

2.  Effects of hyperthermia and/or hyperglycemia on pH and pO2 in well oxygenated xenotransplanted human sarcoma.

Authors:  S Roszinski; G Wiedemann; S Z Jiang; G Baretton; T Wagner; C Weiss
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-06       Impact factor: 7.038

3.  The effect of hyperthermia on vascular function, pH, and cell survival.

Authors:  C W Song; M S Kang; J G Rhee; S H Levitt
Journal:  Radiology       Date:  1980-12       Impact factor: 11.105

Review 4.  Tumour microcirculation as a target for hyperthermia.

Authors:  H S Reinhold; B Endrich
Journal:  Int J Hyperthermia       Date:  1986 Apr-Jun       Impact factor: 3.914

5.  Effect of hyperthermia on a neurogenic rat cell line (BT4A) in vivo.

Authors:  O Dahl
Journal:  Acta Radiol Oncol       Date:  1982

6.  Effect of timing and sequence of hyperthermia and cyclophosphamide on a neurogenic rat tumor (BT4A) in vivo.

Authors:  O Dahl; O Mella
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860

7.  Blood flow in normal tissues and tumors during hyperthermia.

Authors:  C W Song; J G Rhee; S H Levitt
Journal:  J Natl Cancer Inst       Date:  1980-01       Impact factor: 13.506

8.  Response of human tumor blood flow to local hyperthermia.

Authors:  F M Waterman; R E Nerlinger; D J Moylan; D B Leeper
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-01       Impact factor: 7.038

9.  Effect of temperature on the cytotoxicity of vindesine, amsacrine, and mitoxantrone.

Authors:  T S Herman
Journal:  Cancer Treat Rep       Date:  1983-11

10.  Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice.

Authors:  H A Neumann; H H Fiebig; G W Löhr; R Engelhardt
Journal:  J Natl Cancer Inst       Date:  1985-12       Impact factor: 13.506

View more
  2 in total

1.  Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

Authors:  Rolf D Issels; Lars H Lindner; Jaap Verweij; Peter Wust; Peter Reichardt; Baard-Christian Schem; Sultan Abdel-Rahman; Soeren Daugaard; Christoph Salat; Clemens-Martin Wendtner; Zeljko Vujaskovic; Rüdiger Wessalowski; Karl-Walter Jauch; Hans Roland Dürr; Ferdinand Ploner; Andrea Baur-Melnyk; Ulrich Mansmann; Wolfgang Hiddemann; Jean-Yves Blay; Peter Hohenberger
Journal:  Lancet Oncol       Date:  2010-04-29       Impact factor: 41.316

Review 2.  Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.

Authors:  Arlene L Oei; Lianne E M Vriend; Johannes Crezee; Nicolaas A P Franken; Przemek M Krawczyk
Journal:  Radiat Oncol       Date:  2015-08-07       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.